OverviewSuggest Edit

Zimmer Biomet is a musculoskeletal healthcare company. It designs, manufactures, and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, office-based technologies, spine, craniomaxillofacial and thoracic products, dental implants, and related surgical products. Zimmer Biomet's products and solutions help treat patients suffering from disorders and injuries of bones, joints, and supporting soft tissues.

TypePublic
Founded1927
HQWarsaw, IN, US
Websitezimmerbiomet.com
Employee Ratings3.4
Overall CultureD+

Latest Updates

Employees (est.) (Dec 2019)19,900(+5%)
Job Openings432
Revenue (FY, 2020)$7 B(-11%)
Share Price (Jul 2021)$153.4
Cybersecurity ratingBMore

Key People/Management at Zimmer Biomet

Bryan C. Hanson

Bryan C. Hanson

President, Chief Executive Officer & Director
Didier Deltort

Didier Deltort

President, Europe, Middle East and Africa
Chad Phipps

Chad Phipps

Senior Vice President, General Counsel and Secretary
Rachel Ellingson

Rachel Ellingson

Senior Vice President and Chief Strategy Officer
David J. Kunz

David J. Kunz

Senior Vice President, Global Quality and Regulatory Affairs
Ellie Humphrey

Ellie Humphrey

Senior Vice President and Chief Transformation Officer
Show more

Zimmer Biomet Office Locations

Zimmer Biomet has offices in Warsaw, Carlsbad, Dover, Edina and in 48 other locations
Warsaw, IN, US (HQ)
345 E Main St
Carlsbad, CA, US
1900 Aston Ave
Dover, OH, US
200 W Ohio Ave
Edina, MN, US
7375 Bush Lake Rd
Miami, FL, US
6303 Blue Lagoon Dr
Warsaw, IN, US
1800 W Center St
Show all (59)

Zimmer Biomet Financials and Metrics

Zimmer Biomet Revenue

Embed Graph
View revenue for all periods
Zimmer Biomet's revenue was reported to be $7.02 b in FY, 2020
USD

Revenue (Q1, 2021)

1.8b

Gross profit (Q1, 2021)

1.3b

Gross profit margin (Q1, 2021), %

72%

Net income (Q1, 2021)

197.7m

Market capitalization (16-Jul-2021)

32.0b

Closing stock price (16-Jul-2021)

153.4

Cash (31-Mar-2021)

724.3m

EV

38.8b
Zimmer Biomet's current market capitalization is $32 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

7.8b7.9b8.0b7.0b

Revenue growth, %

2%1%1%

Cost of goods sold

2.1b2.3b2.3b2.1b

Gross profit

5.7b5.7b5.7b4.9b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.0b2.0b1.8b2.0b2.0b1.9b1.8b1.2b1.9b1.8b

Cost of goods sold

575.8m583.7m529.0m553.4m581.3m535.7m487.1m424.5m569.4m516.4m

Gross profit

1.4b1.4b1.3b1.4b1.4b1.4b1.3b801.6m1.4b1.3b

Gross profit Margin, %

71%71%71%72%71%72%73%65%70%72%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

524.4m542.8m617.9m802.1m

Accounts Receivable

1.5b1.3b1.4b1.5b

Prepaid Expenses

414.5m352.3m357.1m377.8m

Inventories

2.1b2.3b2.4b2.5b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

1.8b481.2m524.6m586.8m403.1m512.5m2.4b713.4m967.3m724.3m

Accounts Receivable

1.4b1.3b1.3b1.2b1.2b1.2b1.0b1.1b1.3b1.4b

Prepaid Expenses

465.5m500.2m506.5m376.9m396.5m375.9m435.0m432.4m352.4m383.9m

Inventories

2.1b2.2b2.2b2.3b2.3b2.4b2.5b2.5b2.5b2.5b
Show all financial metrics

Zimmer Biomet Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Patents and Patent Applications

4.5 k7 k8 k8 k8.5 k9 k

Countries (Facilities)

4040404040

Manufacturing Facilities

30

Facilities

340
Show all operating metrics

Zimmer Biomet Acquisitions / Subsidiaries

Company NameDateDeal Size
RespondwellOctober 27, 2016
Clinical GraphicsSeptember 15, 2016
CD DiagnosticsAugust 16, 2016
Medtech SASJuly 18, 2016€164 m
Compression Therapy ProductsJune 13, 2016
LDR HoldingJune 07, 2016$1 b
Cayenne MedicalApril 25, 2016
Ortho TransmissionMarch 01, 2016
EtexOctober 01, 2014
ETEX CorporationOctober 01, 2014
Show more

Zimmer Biomet Revenue Breakdown

Embed Graph

Zimmer Biomet revenue breakdown by business segment: 9.4% from Spine & CMF, 5.2% from Dental, 22.5% from S.E.T, 24.2% from Hips, 35.2% from Knees and 3.5% from Other

Zimmer Biomet revenue breakdown by geographic segment: 17.0% from Asia Pacific, 21.9% from EMEA and 61.1% from Americas

Zimmer Biomet Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Zimmer Biomet Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Zimmer Biomet Online and Social Media Presence

Embed Graph

Zimmer Biomet Company Culture

  • Overall Culture

    D+

    61/100

  • CEO Rating

    C+

    67/100

  • Compensation

    B+

    74/100

  • Diversity

    C+

    67/100

Learn more on Comparably

Zimmer Biomet News and Updates

Zimmer Biomet Announces Intent to Spin Off Spine and Dental Businesses

WARSAW, Ind., Feb. 5, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its intention to spin off the Company's Spine and Dental businesses to form a new and independent, publicly traded company ("NewCo")....

Zimmer Biomet Announces Fourth Quarter and Full-Year 2020 Financial Results

WARSAW, Ind., Feb. 5, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2020. The Company reported fourth quarter net sales of $2.085 billion, a decrease of 1.9% from the prior year period,...

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2020 Financial Results

WARSAW, Ind., Jan. 8, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 5, 2021 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that...

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2020

WARSAW, Ind., Dec. 16, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2020....

Zimmer Biomet and Hospital for Special Surgery (HSS) Partner to Advance Innovation on mymobility速 with Apple Watch速 Remote Care Management System

WARSAW, Ind. and NEW YORK, Dec. 9, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, and Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, today announced...

Silicon Valley Orthopaedics Concurs on the Downsides of Delaying Joint Replacement Surgery Highlighted in New Zimmer Biomet Study in USA Today

The study, commissioned by medical device company Zimmer Biomet, was detailed in a recent article published on October 28th, 2020, in USA TODAY titled, “5 Reasons to Reconsider Delaying Joint Replacement Surgery.” In response to the study, the article encourages hesitant patients to consider moving …
Show more

Zimmer Biomet Frequently Asked Questions

  • When was Zimmer Biomet founded?

    Zimmer Biomet was founded in 1927.

  • Who are Zimmer Biomet key executives?

    Zimmer Biomet's key executives are Bryan C. Hanson, Didier Deltort and Chad Phipps.

  • How many employees does Zimmer Biomet have?

    Zimmer Biomet has 19,900 employees.

  • What is Zimmer Biomet revenue?

    Latest Zimmer Biomet annual revenue is $7 b.

  • What is Zimmer Biomet revenue per employee?

    Latest Zimmer Biomet revenue per employee is $353 k.

  • Who are Zimmer Biomet competitors?

    Competitors of Zimmer Biomet include Smith & Nephew, Wright Medical and Globus Medical.

  • Where is Zimmer Biomet headquarters?

    Zimmer Biomet headquarters is located at 345 E Main St, Warsaw.

  • Where are Zimmer Biomet offices?

    Zimmer Biomet has offices in Warsaw, Carlsbad, Dover, Edina and in 48 other locations.

  • How many offices does Zimmer Biomet have?

    Zimmer Biomet has 59 offices.